Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization

Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene (sodium voltage-gated channel alpha subunit 5) in ≈20% of subjects. We identified a family with 4 individuals diagnosed with BrS harboring the rare G145R missense variant...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 147; no. 10; pp. 824 - 840
Main Authors Bersell, Kevin R., Yang, Tao, Mosley, Jonathan D., Glazer, Andrew M., Hale, Andrew T., Kryshtal, Dmytro O., Kim, Kyungsoo, Steimle, Jeffrey D., Brown, Jonathan D., Salem, Joe-Elie, Campbell, Courtney C., Hong, Charles C., Wells, Quinn S., Johnson, Amanda N., Short, Laura, Blair, Marcia A., Behr, Elijah R., Petropoulou, Evmorfia, Jamshidi, Yalda, Benson, Mark D., Keyes, Michelle J., Ngo, Debby, Vasan, Ramachandran S., Yang, Qiong, Gerszten, Robert E., Shaffer, Christian, Parikh, Shan, Sheng, Quanhu, Kannankeril, Prince J., Moskowitz, Ivan P., York, John D., Wang, Thomas J., Knollmann, Bjorn C., Roden, Dan M.
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 07.03.2023
American Heart Association
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene (sodium voltage-gated channel alpha subunit 5) in ≈20% of subjects. We identified a family with 4 individuals diagnosed with BrS harboring the rare G145R missense variant in the cardiac transcription factor (T-box transcription factor 5) and no variant. We generated induced pluripotent stem cells (iPSCs) from 2 members of a family carrying TBX5-G145R and diagnosed with Brugada syndrome. After differentiation to iPSC-derived cardiomyocytes (iPSC-CMs), electrophysiologic characteristics were assessed by voltage- and current-clamp experiments (n=9 to 21 cells per group) and transcriptional differences by RNA sequencing (n=3 samples per group), and compared with iPSC-CMs in which G145R was corrected by CRISPR/Cas9 approaches. The role of platelet-derived growth factor (PDGF)/phosphoinositide 3-kinase (PI3K) pathway was elucidated by small molecule perturbation. The rate-corrected QT (QTc) interval association with serum PDGF was tested in the Framingham Heart Study cohort (n=1893 individuals). TBX5-G145R reduced transcriptional activity and caused multiple electrophysiologic abnormalities, including decreased peak and enhanced "late" cardiac sodium current (I ), which were entirely corrected by editing G145R to wild-type. Transcriptional profiling and functional assays in genome-unedited and -edited iPSC-CMs showed direct down-regulation caused decreased peak I , and that reduced PDGF receptor ( [platelet-derived growth factor receptor α]) expression and blunted signal transduction to PI3K was implicated in enhanced late I . Tbx5 regulation of the PDGF axis increased arrhythmia risk due to disruption of PDGF signaling and was conserved in murine model systems. PDGF receptor blockade markedly prolonged normal iPSC-CM action potentials and plasma levels of PDGF in the Framingham Heart Study were inversely correlated with the QTc interval ( <0.001). These results not only establish decreased transcription by the variant as a cause of BrS, but also reveal a new general transcriptional mechanism of arrhythmogenesis of enhanced late sodium current caused by reduced PDGF receptor-mediated PI3K signaling.
AbstractList Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene (sodium voltage-gated channel alpha subunit 5) in ≈20% of subjects. We identified a family with 4 individuals diagnosed with BrS harboring the rare G145R missense variant in the cardiac transcription factor (T-box transcription factor 5) and no variant. We generated induced pluripotent stem cells (iPSCs) from 2 members of a family carrying TBX5-G145R and diagnosed with Brugada syndrome. After differentiation to iPSC-derived cardiomyocytes (iPSC-CMs), electrophysiologic characteristics were assessed by voltage- and current-clamp experiments (n=9 to 21 cells per group) and transcriptional differences by RNA sequencing (n=3 samples per group), and compared with iPSC-CMs in which G145R was corrected by CRISPR/Cas9 approaches. The role of platelet-derived growth factor (PDGF)/phosphoinositide 3-kinase (PI3K) pathway was elucidated by small molecule perturbation. The rate-corrected QT (QTc) interval association with serum PDGF was tested in the Framingham Heart Study cohort (n=1893 individuals). TBX5-G145R reduced transcriptional activity and caused multiple electrophysiologic abnormalities, including decreased peak and enhanced "late" cardiac sodium current (I ), which were entirely corrected by editing G145R to wild-type. Transcriptional profiling and functional assays in genome-unedited and -edited iPSC-CMs showed direct down-regulation caused decreased peak I , and that reduced PDGF receptor ( [platelet-derived growth factor receptor α]) expression and blunted signal transduction to PI3K was implicated in enhanced late I . Tbx5 regulation of the PDGF axis increased arrhythmia risk due to disruption of PDGF signaling and was conserved in murine model systems. PDGF receptor blockade markedly prolonged normal iPSC-CM action potentials and plasma levels of PDGF in the Framingham Heart Study were inversely correlated with the QTc interval ( <0.001). These results not only establish decreased transcription by the variant as a cause of BrS, but also reveal a new general transcriptional mechanism of arrhythmogenesis of enhanced late sodium current caused by reduced PDGF receptor-mediated PI3K signaling.
BACKGROUND: Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene SCN5A (sodium voltage-gated channel alpha subunit 5) in ≈20% of subjects. We identified a family with 4 individuals diagnosed with BrS harboring the rare G145R missense variant in the cardiac transcription factor TBX5 (T-box transcription factor 5) and no SCN5A variant. METHODS: We generated induced pluripotent stem cells (iPSCs) from 2 members of a family carrying TBX5-G145R and diagnosed with Brugada syndrome. After differentiation to iPSC-derived cardiomyocytes (iPSC-CMs), electrophysiologic characteristics were assessed by voltage- and current-clamp experiments (n=9 to 21 cells per group) and transcriptional differences by RNA sequencing (n=3 samples per group), and compared with iPSC-CMs in which G145R was corrected by CRISPR/Cas9 approaches. The role of platelet-derived growth factor (PDGF)/phosphoinositide 3-kinase (PI3K) pathway was elucidated by small molecule perturbation. The corrected QT (QTc) interval association with serum PDGF was tested in the Framingham Heart Study cohort (n=1893 individuals). RESULTS: TBX5-G145R reduced transcriptional activity and caused multiple electrophysiologic abnormalities, including decreased peak and enhanced “late” cardiac sodium current (I Na ), which were entirely corrected by editing G145R to wild-type. Transcriptional profiling and functional assays in genome-unedited and -edited iPSC-CMs showed direct SCN5A down-regulation caused decreased peak I Na , and that reduced PDGF receptor ( PDGFRA [platelet-derived growth factor receptor α]) expression and blunted signal transduction to PI3K was implicated in enhanced late I Na . Tbx5 regulation of the PDGF axis and disruption of PDGF signaling, which causes arrhythmia risk, were both conserved in murine model systems. The PDGF receptor blockade markedly prolonged normal iPSC-CM action potentials and plasma levels of PDGF in the Framingham Heart Study were inversely correlated with the QTc interval ( P <0.001). CONCLUSIONS: These results not only establish decreased SCN5A transcription by the TBX5 variant as a cause of BrS, but also reveal a new general transcriptional mechanism of arrhythmogenesis of enhanced late sodium current caused by reduced PDGF receptor–mediated PI3K signaling.
Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene SCN5A (sodium voltage-gated channel alpha subunit 5) in ≈20% of subjects. We identified a family with 4 individuals diagnosed with BrS harboring the rare G145R missense variant in the cardiac transcription factor TBX5 (T-box transcription factor 5) and no SCN5A variant.BACKGROUNDBrugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene SCN5A (sodium voltage-gated channel alpha subunit 5) in ≈20% of subjects. We identified a family with 4 individuals diagnosed with BrS harboring the rare G145R missense variant in the cardiac transcription factor TBX5 (T-box transcription factor 5) and no SCN5A variant.We generated induced pluripotent stem cells (iPSCs) from 2 members of a family carrying TBX5-G145R and diagnosed with Brugada syndrome. After differentiation to iPSC-derived cardiomyocytes (iPSC-CMs), electrophysiologic characteristics were assessed by voltage- and current-clamp experiments (n=9 to 21 cells per group) and transcriptional differences by RNA sequencing (n=3 samples per group), and compared with iPSC-CMs in which G145R was corrected by CRISPR/Cas9 approaches. The role of platelet-derived growth factor (PDGF)/phosphoinositide 3-kinase (PI3K) pathway was elucidated by small molecule perturbation. The rate-corrected QT (QTc) interval association with serum PDGF was tested in the Framingham Heart Study cohort (n=1893 individuals).METHODSWe generated induced pluripotent stem cells (iPSCs) from 2 members of a family carrying TBX5-G145R and diagnosed with Brugada syndrome. After differentiation to iPSC-derived cardiomyocytes (iPSC-CMs), electrophysiologic characteristics were assessed by voltage- and current-clamp experiments (n=9 to 21 cells per group) and transcriptional differences by RNA sequencing (n=3 samples per group), and compared with iPSC-CMs in which G145R was corrected by CRISPR/Cas9 approaches. The role of platelet-derived growth factor (PDGF)/phosphoinositide 3-kinase (PI3K) pathway was elucidated by small molecule perturbation. The rate-corrected QT (QTc) interval association with serum PDGF was tested in the Framingham Heart Study cohort (n=1893 individuals).TBX5-G145R reduced transcriptional activity and caused multiple electrophysiologic abnormalities, including decreased peak and enhanced "late" cardiac sodium current (INa), which were entirely corrected by editing G145R to wild-type. Transcriptional profiling and functional assays in genome-unedited and -edited iPSC-CMs showed direct SCN5A down-regulation caused decreased peak INa, and that reduced PDGF receptor (PDGFRA [platelet-derived growth factor receptor α]) expression and blunted signal transduction to PI3K was implicated in enhanced late INa. Tbx5 regulation of the PDGF axis increased arrhythmia risk due to disruption of PDGF signaling and was conserved in murine model systems. PDGF receptor blockade markedly prolonged normal iPSC-CM action potentials and plasma levels of PDGF in the Framingham Heart Study were inversely correlated with the QTc interval (P<0.001).RESULTSTBX5-G145R reduced transcriptional activity and caused multiple electrophysiologic abnormalities, including decreased peak and enhanced "late" cardiac sodium current (INa), which were entirely corrected by editing G145R to wild-type. Transcriptional profiling and functional assays in genome-unedited and -edited iPSC-CMs showed direct SCN5A down-regulation caused decreased peak INa, and that reduced PDGF receptor (PDGFRA [platelet-derived growth factor receptor α]) expression and blunted signal transduction to PI3K was implicated in enhanced late INa. Tbx5 regulation of the PDGF axis increased arrhythmia risk due to disruption of PDGF signaling and was conserved in murine model systems. PDGF receptor blockade markedly prolonged normal iPSC-CM action potentials and plasma levels of PDGF in the Framingham Heart Study were inversely correlated with the QTc interval (P<0.001).These results not only establish decreased SCN5A transcription by the TBX5 variant as a cause of BrS, but also reveal a new general transcriptional mechanism of arrhythmogenesis of enhanced late sodium current caused by reduced PDGF receptor-mediated PI3K signaling.CONCLUSIONSThese results not only establish decreased SCN5A transcription by the TBX5 variant as a cause of BrS, but also reveal a new general transcriptional mechanism of arrhythmogenesis of enhanced late sodium current caused by reduced PDGF receptor-mediated PI3K signaling.
Author Kryshtal, Dmytro O.
Vasan, Ramachandran S.
Kannankeril, Prince J.
Wang, Thomas J.
Yang, Tao
Shaffer, Christian
Petropoulou, Evmorfia
Jamshidi, Yalda
Moskowitz, Ivan P.
Johnson, Amanda N.
Roden, Dan M.
Glazer, Andrew M.
Yang, Qiong
York, John D.
Wells, Quinn S.
Keyes, Michelle J.
Behr, Elijah R.
Brown, Jonathan D.
Hong, Charles C.
Blair, Marcia A.
Gerszten, Robert E.
Knollmann, Bjorn C.
Benson, Mark D.
Ngo, Debby
Kim, Kyungsoo
Campbell, Courtney C.
Parikh, Shan
Bersell, Kevin R.
Steimle, Jeffrey D.
Sheng, Quanhu
Mosley, Jonathan D.
Short, Laura
Salem, Joe-Elie
Hale, Andrew T.
AuthorAffiliation Biochemistry (A.T.H., J.D.Y.), Vanderbilt University, Nashville, TN
Department of Medicine, University of Maryland School of Medicine, Baltimore (C.C.H.)
Boston University School of Medicine, MA (R.S.V., Q.Y.)
Medicine (T.Y., J.D.M., J.D.B., J-E.S., Q.S.W., L.S., M.A.B., C.S., T.J.W., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
Molecular Physiology and Biophysics (A.N.J.), Vanderbilt University, Nashville, TN
Departments of Pediatrics, Pathology, and Human Genetics, University of Chicago, IL (J.D.S., I.P.M.)
Cardiology Clinical Academic Group, Molecular and Clinical Sciences Institute, St George’s, University of London and St George’s University Hospitals National Health Service Foundation Trust, London, UK (E.P., Y.J.)
Cardiovascular Research Center (E.J.B., M.D.B., M.J.K., R.E.G.), Beth Israel Deaconess Hospital, Boston, MA
Pediatrics (P.J.K.), Vanderbilt University, Nashville, TN
Division of Pulmonary and Cardiovascular Medicine (D.N., R.E.G.), Beth Israel Deaconess Hospital, Bosto
AuthorAffiliation_xml – name: Boston University School of Medicine, MA (R.S.V., Q.Y.)
– name: Pediatrics (P.J.K.), Vanderbilt University, Nashville, TN
– name: Medicine (T.Y., J.D.M., J.D.B., J-E.S., Q.S.W., L.S., M.A.B., C.S., T.J.W., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– name: Departments of Pediatrics, Pathology, and Human Genetics, University of Chicago, IL (J.D.S., I.P.M.)
– name: Biochemistry (A.T.H., J.D.Y.), Vanderbilt University, Nashville, TN
– name: Department of Medicine, University of Maryland School of Medicine, Baltimore (C.C.H.)
– name: Division of Pulmonary and Cardiovascular Medicine (D.N., R.E.G.), Beth Israel Deaconess Hospital, Boston, MA
– name: Cardiovascular Research Center (E.J.B., M.D.B., M.J.K., R.E.G.), Beth Israel Deaconess Hospital, Boston, MA
– name: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– name: Molecular Physiology and Biophysics (A.N.J.), Vanderbilt University, Nashville, TN
– name: Cardiology Clinical Academic Group, Molecular and Clinical Sciences Institute, St George’s, University of London and St George’s University Hospitals National Health Service Foundation Trust, London, UK (E.P., Y.J.)
Author_xml – sequence: 1
  givenname: Kevin R.
  surname: Bersell
  fullname: Bersell, Kevin R.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 2
  givenname: Tao
  surname: Yang
  fullname: Yang, Tao
  organization: Medicine (T.Y., J.D.M., J.D.B., J-E.S., Q.S.W., L.S., M.A.B., C.S., T.J.W., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 3
  givenname: Jonathan D.
  surname: Mosley
  fullname: Mosley, Jonathan D.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 4
  givenname: Andrew M.
  surname: Glazer
  fullname: Glazer, Andrew M.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 5
  givenname: Andrew T.
  surname: Hale
  fullname: Hale, Andrew T.
  organization: Biochemistry (A.T.H., J.D.Y.), Vanderbilt University, Nashville, TN
– sequence: 6
  givenname: Dmytro O.
  surname: Kryshtal
  fullname: Kryshtal, Dmytro O.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 7
  givenname: Kyungsoo
  surname: Kim
  fullname: Kim, Kyungsoo
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 8
  givenname: Jeffrey D.
  surname: Steimle
  fullname: Steimle, Jeffrey D.
  organization: Departments of Pediatrics, Pathology, and Human Genetics, University of Chicago, IL (J.D.S., I.P.M.)
– sequence: 9
  givenname: Jonathan D.
  surname: Brown
  fullname: Brown, Jonathan D.
  organization: Medicine (T.Y., J.D.M., J.D.B., J-E.S., Q.S.W., L.S., M.A.B., C.S., T.J.W., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 10
  givenname: Joe-Elie
  surname: Salem
  fullname: Salem, Joe-Elie
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 11
  givenname: Courtney C.
  surname: Campbell
  fullname: Campbell, Courtney C.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 12
  givenname: Charles C.
  surname: Hong
  fullname: Hong, Charles C.
  organization: Department of Medicine, University of Maryland School of Medicine, Baltimore (C.C.H.)
– sequence: 13
  givenname: Quinn S.
  surname: Wells
  fullname: Wells, Quinn S.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 14
  givenname: Amanda N.
  surname: Johnson
  fullname: Johnson, Amanda N.
  organization: Molecular Physiology and Biophysics (A.N.J.), Vanderbilt University, Nashville, TN
– sequence: 15
  givenname: Laura
  surname: Short
  fullname: Short, Laura
  organization: Medicine (T.Y., J.D.M., J.D.B., J-E.S., Q.S.W., L.S., M.A.B., C.S., T.J.W., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 16
  givenname: Marcia A.
  surname: Blair
  fullname: Blair, Marcia A.
  organization: Medicine (T.Y., J.D.M., J.D.B., J-E.S., Q.S.W., L.S., M.A.B., C.S., T.J.W., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 17
  givenname: Elijah R.
  surname: Behr
  fullname: Behr, Elijah R.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 18
  givenname: Evmorfia
  surname: Petropoulou
  fullname: Petropoulou, Evmorfia
  organization: Cardiology Clinical Academic Group, Molecular and Clinical Sciences Institute, St George’s, University of London and St George’s University Hospitals National Health Service Foundation Trust, London, UK (E.P., Y.J.)
– sequence: 19
  givenname: Yalda
  surname: Jamshidi
  fullname: Jamshidi, Yalda
  organization: Cardiology Clinical Academic Group, Molecular and Clinical Sciences Institute, St George’s, University of London and St George’s University Hospitals National Health Service Foundation Trust, London, UK (E.P., Y.J.)
– sequence: 20
  givenname: Mark D.
  surname: Benson
  fullname: Benson, Mark D.
  organization: Cardiovascular Research Center (E.J.B., M.D.B., M.J.K., R.E.G.), Beth Israel Deaconess Hospital, Boston, MA
– sequence: 21
  givenname: Michelle J.
  surname: Keyes
  fullname: Keyes, Michelle J.
  organization: Cardiovascular Research Center (E.J.B., M.D.B., M.J.K., R.E.G.), Beth Israel Deaconess Hospital, Boston, MA
– sequence: 22
  givenname: Debby
  surname: Ngo
  fullname: Ngo, Debby
  organization: Division of Pulmonary and Cardiovascular Medicine (D.N., R.E.G.), Beth Israel Deaconess Hospital, Boston, MA
– sequence: 23
  givenname: Ramachandran S.
  surname: Vasan
  fullname: Vasan, Ramachandran S.
  organization: Boston University School of Medicine, MA (R.S.V., Q.Y.)
– sequence: 24
  givenname: Qiong
  surname: Yang
  fullname: Yang, Qiong
  organization: Boston University School of Medicine, MA (R.S.V., Q.Y.)
– sequence: 25
  givenname: Robert E.
  surname: Gerszten
  fullname: Gerszten, Robert E.
  organization: Cardiovascular Research Center (E.J.B., M.D.B., M.J.K., R.E.G.), Beth Israel Deaconess Hospital, Boston, MA
– sequence: 26
  givenname: Christian
  surname: Shaffer
  fullname: Shaffer, Christian
  organization: Medicine (T.Y., J.D.M., J.D.B., J-E.S., Q.S.W., L.S., M.A.B., C.S., T.J.W., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 27
  givenname: Shan
  surname: Parikh
  fullname: Parikh, Shan
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 28
  givenname: Quanhu
  surname: Sheng
  fullname: Sheng, Quanhu
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 29
  givenname: Prince J.
  surname: Kannankeril
  fullname: Kannankeril, Prince J.
  organization: Pediatrics (P.J.K.), Vanderbilt University, Nashville, TN
– sequence: 30
  givenname: Ivan P.
  surname: Moskowitz
  fullname: Moskowitz, Ivan P.
  organization: Departments of Pediatrics, Pathology, and Human Genetics, University of Chicago, IL (J.D.S., I.P.M.)
– sequence: 31
  givenname: John D.
  surname: York
  fullname: York, John D.
  organization: Biochemistry (A.T.H., J.D.Y.), Vanderbilt University, Nashville, TN
– sequence: 32
  givenname: Thomas J.
  surname: Wang
  fullname: Wang, Thomas J.
  organization: Medicine (T.Y., J.D.M., J.D.B., J-E.S., Q.S.W., L.S., M.A.B., C.S., T.J.W., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 33
  givenname: Bjorn C.
  surname: Knollmann
  fullname: Knollmann, Bjorn C.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
– sequence: 34
  givenname: Dan M.
  surname: Roden
  fullname: Roden, Dan M.
  organization: Departments of Pharmacology (K.R.B., A.M.G., D.O.K., K.K., J-E.S., C.C.C., Q.S.W., S.P., B.C.K., D.M.R.), Vanderbilt University, Nashville, TN
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36524479$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04002896$$DView record in HAL
BookMark eNqNksFv0zAYxS00xLrBv4DMDQ4ptpPY8QmFwGiljkmjPVtO4iwGxy52ypT99bjNmAQnTvZn_d6T9d53Ac6sswqANxgtMab4fbW-rXabcru--VquyiUmZIkowTx9BhY4J1mS5Sk_AwuEEE9YSsg5uAjhexxpyvIX4DylkcoYX4Bp66UNjdf7UTsrDfw0Ba_uDkYeZ7izrfJGqwA_urGH1866O2V1A0vv-2nsBy3ht8m23g0KStvCyg1D1F27Vnda-QBdByvpWy0beKv2zkivH07eL8HzTpqgXj2el2B39XlbrZLNzZd1VW6SJv6QJg2TeV5TppqslilvaFvTVjGMcYc4RUzxQuWkqOuMqCPUtYQVhKeEU1JzgtJL8G727aURe68H6SfhpBarciOObyhDiBSc_sKRfTuze-9-HlQYxaBDo4yRVrlDEITleV4gykhEXz-ih3pQ7ZPzn2gjwGeg8S7ETLsnBCNxrFH8XaOINYq5xqj98I-20eMptdFLbf7LIZsd7p0ZYw8_zOFeedEracZexE1AKcIsIYik8cZQgk7b8Rs9q7YX
CitedBy_id crossref_primary_10_1016_j_hrthm_2023_11_004
crossref_primary_10_1038_s44161_024_00451_x
crossref_primary_10_3390_ijms24076687
crossref_primary_10_1016_j_hrthm_2023_05_006
crossref_primary_10_3390_biomedicines11082297
crossref_primary_10_1093_europace_euae152
crossref_primary_10_1172_JCI180670
crossref_primary_10_14814_phy2_15696
crossref_primary_10_1016_j_hrthm_2024_04_059
crossref_primary_10_3390_biomedicines13010027
crossref_primary_10_1161_JAHA_122_022352
Cites_doi 10.1093/nar/gkv007
10.1016/j.tcm.2015.05.006
10.1161/CIRCULATIONAHA.118.035070
10.1161/01.cir.86.5.1376
10.1093/bioinformatics/btt656
10.1161/01.cir.89.4.1681
10.1161/CIRCULATIONAHA.119.043132
10.1155/2014/986048
10.1016/0735-1097(92)90253-j
10.1016/s0735-1097(00)00962-1
10.1161/CIRCRESAHA.117.310959
10.1038/nprot.2013.143
10.1016/j.cell.2016.11.033
10.1152/ajpheart.00071.2017
10.1093/bioinformatics/btt703
10.1016/j.hrthm.2013.03.014
10.1126/scitranslmed.3003623
10.1016/j.jacc.2014.04.032
10.1161/CIRCGENETICS.110.959130
10.1016/j.hrthm.2011.02.021
10.1016/j.jacc.2009.10.033
10.1186/1475-925X-10-17
10.1093/cvr/cvv042
10.1016/j.stem.2013.05.016
10.1016/j.hrthm.2010.06.016
10.1124/jpet.117.246157
10.1038/ng.2712
10.1126/science.aaa5458
10.3389/fphar.2013.00078
10.1126/scitranslmed.aaf4891
10.1093/eurheartj/ehv445
10.1111/bph.14223
10.1002/humu.22328
10.1172/JCI73140
10.1177/2211068214562832
10.1161/CIRCULATIONAHA.116.021803
10.1016/j.hrthm.2020.07.038
10.1016/j.hrthm.2011.12.006
10.1038/ncomms7955
10.1161/CIRCEP.111.969972
10.1016/j.bpj.2011.09.060
10.1016/s0092-8674(01)00493-7
10.1111/j.1445-5994.1995.tb00573.x
10.1016/j.hrthm.2010.08.026
10.1016/j.yjmcc.2017.12.002
10.1016/0091-7435(75)90037-7
10.1161/CIRCULATIONAHA.106.646513
10.1016/j.cjca.2011.11.011
10.1093/hmg/10.18.1983
10.1161/CIRCULATIONAHA.106.668392
10.1093/nar/gkaa1106
10.1152/ajpheart.00306.2013
10.1016/0022-0736(88)90096-9
10.1016/j.cardiores.2005.06.027
10.1016/j.hrthm.2020.06.027
10.1172/JCI62613
10.1093/bioinformatics/btp616
10.1038/ng.716
10.1161/CIRCULATIONAHA.113.007765
10.1161/01.cir.97.5.457
10.1016/j.acvd.2016.12.011
10.1161/CIRCEP.110.959619
10.1161/CIRCGENETICS.114.000831
10.1161/01.cir.103.5.670
10.1016/j.clml.2021.09.002
10.1186/gb-2013-14-4-r36
10.1172/JCI87968
10.7554/eLife.41814
10.1016/j.jacc.2012.04.037
10.1371/journal.pone.0015004
10.1161/CIRCULATIONAHA.110.000661
10.1126/sciadv.abk0052
10.1016/j.yjmcc.2004.11.005
10.1093/bioinformatics/bts635
10.1161/CIRCEP.107.748103
10.1073/pnas.96.6.2919
10.1093/europace/euv078
10.1016/j.jelectrocard.2006.05.030
10.1161/CIRCGENETICS.113.000292
10.1136/openhrt-2013-000031
10.1172/JCI33891
10.1504/ijcbdd.2015.072082
10.1161/01.res.87.10.910
10.1161/01.CIR.0000145162.64183.C8
10.1093/cvr/cvab045
10.1093/bioinformatics/btr174
10.3389/fphys.2013.00179
10.1172/JCI39942
10.1126/scitranslmed.aaf2584
10.1038/s41586-019-1406-x
10.1161/CIRCULATIONAHA.107.703330
10.1016/j.jacc.2016.07.779
10.1007/978-1-0716-0167-9_7
10.1053/euhj.1997.0865
10.1016/j.devcel.2016.01.009
10.1111/bph.13563
10.1161/CIRCEP.117.005282
10.2337/db13-0420
10.1016/j.ijcard.2014.04.133
10.1016/j.cardiores.2004.09.021
10.1371/journal.pone.0054131
10.1038/srep04670
10.1128/MCB.01923-08
10.1161/01.CIR.0000139333.83620.5D
10.1038/32675
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: Lippincott Williams & Wilkins
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
DOI 10.1161/CIRCULATIONAHA.122.062193
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 840
ExternalDocumentID oai_HAL_hal_04002896v1
36524479
10_1161_CIRCULATIONAHA_122_062193
00003017-202303070-00006
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: T32 HL007381
– fundername: NCRR NIH HHS
  grantid: UL1 RR024975
– fundername: NINDS NIH HHS
  grantid: T32 NS007491
– fundername: NIGMS NIH HHS
  grantid: T32 GM007183
– fundername: NIGMS NIH HHS
  grantid: P50 GM115305
– fundername: NHGRI NIH HHS
  grantid: R00 HG010904
– fundername: NIGMS NIH HHS
  grantid: R01 GM115892
– fundername: NHLBI NIH HHS
  grantid: F30 HL127962
– fundername: NCI NIH HHS
  grantid: P30 CA068485
– fundername: NHLBI NIH HHS
  grantid: R35 HL144980
GroupedDBID ---
.-D
.3C
.XZ
.Z2
01R
0R~
0ZK
18M
1J1
29B
2FS
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAWTL
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACOAL
ACRKK
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADCYY
ADGGA
ADHPY
AE3
AE6
AEBDS
AENEX
AFBFQ
AFCHL
AFDTB
AFEXH
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
ASPBG
AVWKF
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C45
CS3
DIK
DIWNM
DU5
E3Z
EBS
EEVPB
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
GNXGY
GQDEL
GX1
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OBH
OCB
ODMTH
OGEVE
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
YOC
YSK
YYM
YZZ
ZFV
ZY1
~H1
AAFWJ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADSXY
.55
.GJ
1CY
1XC
41~
AAEJM
ACCJW
ADFPA
ADNKB
AEETU
AFFNX
AJJEV
AJNYG
BS7
C1A
DUNZO
E.X
EJD
FEDTE
FL-
FW0
H13
HVGLF
H~9
J5H
JK8
M18
MVM
N4W
NEJ
N~M
OCUKA
ODA
OHT
ORVUJ
OUVQU
P-K
R58
WHG
X7M
YQJ
YXB
YYP
ZGI
ZXP
ZZMQN
ID FETCH-LOGICAL-c4476-c7a55b67ec4ba39c6db6de7111f09607e98e528bb42e7ec4fd2782932962b9203
ISSN 0009-7322
1524-4539
IngestDate Wed Aug 13 07:44:49 EDT 2025
Tue Aug 05 09:41:47 EDT 2025
Mon Jul 21 06:08:14 EDT 2025
Tue Jul 01 02:45:22 EDT 2025
Thu Apr 24 23:09:44 EDT 2025
Fri May 16 03:52:43 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords stem cells
genetics
Brugada syndrome
arrhythmia
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4476-c7a55b67ec4ba39c6db6de7111f09607e98e528bb42e7ec4fd2782932962b9203
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6302-0389
0000-0003-2869-0659
0000-0001-7594-6747
0000-0003-3899-0313
0000-0002-0427-6587
0000-0003-0014-4963
0000-0002-3938-4713
0000-0002-6767-7687
0000-0001-7357-5970
0000-0003-4063-6508
0000-0003-4956-9735
0000-0002-3658-1375
0000-0001-6421-2887
0000-0002-0331-3307
0000-0001-8951-9295
0000-0002-3176-4519
0000-0002-0359-6167
0000-0003-0151-6482
0000-0002-1529-9872
0000-0003-0303-1390
0000-0002-8731-2853
0000-0003-2681-3475
0000-0002-0424-8252
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/9992308
PMID 36524479
PQID 2755580672
PQPubID 23479
PageCount 17
ParticipantIDs hal_primary_oai_HAL_hal_04002896v1
proquest_miscellaneous_2755580672
pubmed_primary_36524479
crossref_primary_10_1161_CIRCULATIONAHA_122_062193
crossref_citationtrail_10_1161_CIRCULATIONAHA_122_062193
wolterskluwer_health_00003017-202303070-00006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-March-07
PublicationDateYYYYMMDD 2023-03-07
PublicationDate_xml – month: 03
  year: 2023
  text: 2023-March-07
  day: 07
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2023
Publisher Lippincott Williams & Wilkins
American Heart Association
Publisher_xml – name: Lippincott Williams & Wilkins
– name: American Heart Association
References e_1_3_3_96_2
e_1_3_3_50_2
e_1_3_3_77_2
e_1_3_3_16_2
e_1_3_3_39_2
e_1_3_3_12_2
e_1_3_3_58_2
e_1_3_3_35_2
e_1_3_3_92_2
e_1_3_3_54_2
e_1_3_3_31_2
e_1_3_3_73_2
e_1_3_3_61_2
e_1_3_3_88_2
e_1_3_3_5_2
e_1_3_3_105_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_23_2
e_1_3_3_69_2
e_1_3_3_46_2
e_1_3_3_80_2
e_1_3_3_65_2
e_1_3_3_84_2
e_1_3_3_101_2
e_1_3_3_76_2
e_1_3_3_99_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_57_2
e_1_3_3_91_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_53_2
e_1_3_3_72_2
e_1_3_3_95_2
e_1_3_3_60_2
e_1_3_3_87_2
e_1_3_3_8_2
e_1_3_3_104_2
e_1_3_3_49_2
e_1_3_3_26_2
e_1_3_3_45_2
e_1_3_3_68_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
e_1_3_3_64_2
e_1_3_3_83_2
e_1_3_3_100_2
e_1_3_3_75_2
e_1_3_3_71_2
e_1_3_3_98_2
e_1_3_3_79_2
e_1_3_3_18_2
e_1_3_3_37_2
e_1_3_3_90_2
e_1_3_3_14_2
e_1_3_3_56_2
e_1_3_3_33_2
e_1_3_3_94_2
e_1_3_3_10_2
e_1_3_3_52_2
e_1_3_3_40_2
e_1_3_3_86_2
e_1_3_3_107_2
e_1_3_3_7_2
e_1_3_3_29_2
e_1_3_3_48_2
e_1_3_3_25_2
e_1_3_3_67_2
e_1_3_3_44_2
e_1_3_3_82_2
e_1_3_3_103_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_63_2
e_1_3_3_51_2
e_1_3_3_74_2
e_1_3_3_97_2
e_1_3_3_70_2
e_1_3_3_78_2
e_1_3_3_17_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_59_2
e_1_3_3_32_2
e_1_3_3_55_2
e_1_3_3_93_2
e_1_3_3_62_2
e_1_3_3_85_2
e_1_3_3_89_2
Yang T HC (e_1_3_3_42_2) 2015; 12
e_1_3_3_6_2
e_1_3_3_106_2
e_1_3_3_28_2
e_1_3_3_24_2
e_1_3_3_47_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_43_2
e_1_3_3_66_2
e_1_3_3_81_2
e_1_3_3_102_2
References_xml – ident: e_1_3_3_18_2
  doi: 10.1093/nar/gkv007
– ident: e_1_3_3_25_2
  doi: 10.1016/j.tcm.2015.05.006
– ident: e_1_3_3_8_2
  doi: 10.1161/CIRCULATIONAHA.118.035070
– ident: e_1_3_3_21_2
  doi: 10.1161/01.cir.86.5.1376
– ident: e_1_3_3_76_2
  doi: 10.1093/bioinformatics/btt656
– ident: e_1_3_3_22_2
  doi: 10.1161/01.cir.89.4.1681
– ident: e_1_3_3_47_2
  doi: 10.1161/CIRCULATIONAHA.119.043132
– volume: 12
  start-page: S150
  year: 2015
  ident: e_1_3_3_42_2
  article-title: Inhibition of the α-subunit of PI3 kinase increases late sodium current (INa-L) and generates arrhythmias.
  publication-title: Heart Rhythm
– ident: e_1_3_3_77_2
  doi: 10.1155/2014/986048
– ident: e_1_3_3_4_2
  doi: 10.1016/0735-1097(92)90253-j
– ident: e_1_3_3_57_2
  doi: 10.1016/s0735-1097(00)00962-1
– ident: e_1_3_3_33_2
  doi: 10.1161/CIRCRESAHA.117.310959
– ident: e_1_3_3_66_2
  doi: 10.1038/nprot.2013.143
– ident: e_1_3_3_36_2
  doi: 10.1016/j.cell.2016.11.033
– ident: e_1_3_3_71_2
  doi: 10.1152/ajpheart.00071.2017
– ident: e_1_3_3_82_2
  doi: 10.1093/bioinformatics/btt703
– ident: e_1_3_3_53_2
  doi: 10.1016/j.hrthm.2013.03.014
– ident: e_1_3_3_39_2
  doi: 10.1126/scitranslmed.3003623
– ident: e_1_3_3_107_2
  doi: 10.1016/j.jacc.2014.04.032
– ident: e_1_3_3_100_2
  doi: 10.1161/CIRCGENETICS.110.959130
– ident: e_1_3_3_102_2
  doi: 10.1016/j.hrthm.2011.02.021
– ident: e_1_3_3_67_2
  doi: 10.1016/j.jacc.2009.10.033
– ident: e_1_3_3_74_2
  doi: 10.1186/1475-925X-10-17
– ident: e_1_3_3_11_2
  doi: 10.1093/cvr/cvv042
– ident: e_1_3_3_60_2
  doi: 10.1016/j.stem.2013.05.016
– ident: e_1_3_3_99_2
  doi: 10.1016/j.hrthm.2010.06.016
– ident: e_1_3_3_43_2
  doi: 10.1124/jpet.117.246157
– ident: e_1_3_3_37_2
  doi: 10.1038/ng.2712
– ident: e_1_3_3_61_2
  doi: 10.1126/science.aaa5458
– ident: e_1_3_3_23_2
  doi: 10.3389/fphar.2013.00078
– ident: e_1_3_3_46_2
  doi: 10.1126/scitranslmed.aaf4891
– ident: e_1_3_3_20_2
  doi: 10.1093/eurheartj/ehv445
– ident: e_1_3_3_72_2
  doi: 10.1111/bph.14223
– ident: e_1_3_3_105_2
  doi: 10.1002/humu.22328
– ident: e_1_3_3_34_2
  doi: 10.1172/JCI73140
– ident: e_1_3_3_31_2
  doi: 10.1177/2211068214562832
– ident: e_1_3_3_84_2
  doi: 10.1161/CIRCULATIONAHA.116.021803
– ident: e_1_3_3_59_2
  doi: 10.1016/j.hrthm.2020.07.038
– ident: e_1_3_3_97_2
  doi: 10.1016/j.hrthm.2011.12.006
– ident: e_1_3_3_3_2
  doi: 10.1038/ncomms7955
– ident: e_1_3_3_103_2
  doi: 10.1161/CIRCEP.111.969972
– ident: e_1_3_3_30_2
  doi: 10.1016/j.bpj.2011.09.060
– ident: e_1_3_3_16_2
  doi: 10.1016/s0092-8674(01)00493-7
– ident: e_1_3_3_29_2
  doi: 10.1111/j.1445-5994.1995.tb00573.x
– ident: e_1_3_3_92_2
  doi: 10.1016/j.hrthm.2010.08.026
– ident: e_1_3_3_32_2
  doi: 10.1016/j.yjmcc.2017.12.002
– ident: e_1_3_3_83_2
  doi: 10.1016/0091-7435(75)90037-7
– ident: e_1_3_3_41_2
  doi: 10.1161/CIRCULATIONAHA.106.646513
– ident: e_1_3_3_94_2
  doi: 10.1016/j.cjca.2011.11.011
– ident: e_1_3_3_64_2
  doi: 10.1093/hmg/10.18.1983
– ident: e_1_3_3_91_2
  doi: 10.1161/CIRCULATIONAHA.106.668392
– ident: e_1_3_3_79_2
  doi: 10.1093/nar/gkaa1106
– ident: e_1_3_3_50_2
  doi: 10.1152/ajpheart.00306.2013
– ident: e_1_3_3_86_2
  doi: 10.1016/0022-0736(88)90096-9
– ident: e_1_3_3_98_2
  doi: 10.1016/j.cardiores.2005.06.027
– ident: e_1_3_3_38_2
  doi: 10.1016/j.hrthm.2020.06.027
– ident: e_1_3_3_12_2
  doi: 10.1172/JCI62613
– ident: e_1_3_3_17_2
  doi: 10.1093/bioinformatics/btp616
– ident: e_1_3_3_13_2
  doi: 10.1038/ng.716
– ident: e_1_3_3_26_2
  doi: 10.1161/CIRCULATIONAHA.113.007765
– ident: e_1_3_3_5_2
  doi: 10.1161/01.cir.97.5.457
– ident: e_1_3_3_89_2
  doi: 10.1016/j.acvd.2016.12.011
– ident: e_1_3_3_101_2
  doi: 10.1161/CIRCEP.110.959619
– ident: e_1_3_3_9_2
  doi: 10.1161/CIRCGENETICS.114.000831
– ident: e_1_3_3_62_2
  doi: 10.1161/01.cir.103.5.670
– ident: e_1_3_3_52_2
  doi: 10.1016/j.clml.2021.09.002
– ident: e_1_3_3_80_2
  doi: 10.1186/gb-2013-14-4-r36
– ident: e_1_3_3_35_2
  doi: 10.1172/JCI87968
– ident: e_1_3_3_45_2
  doi: 10.7554/eLife.41814
– ident: e_1_3_3_93_2
  doi: 10.1016/j.jacc.2012.04.037
– ident: e_1_3_3_85_2
  doi: 10.1371/journal.pone.0015004
– ident: e_1_3_3_68_2
  doi: 10.1161/CIRCULATIONAHA.110.000661
– ident: e_1_3_3_54_2
  doi: 10.1126/sciadv.abk0052
– ident: e_1_3_3_63_2
  doi: 10.1016/j.yjmcc.2004.11.005
– ident: e_1_3_3_75_2
  doi: 10.1093/bioinformatics/bts635
– ident: e_1_3_3_96_2
  doi: 10.1161/CIRCEP.107.748103
– ident: e_1_3_3_14_2
  doi: 10.1073/pnas.96.6.2919
– ident: e_1_3_3_106_2
  doi: 10.1093/europace/euv078
– ident: e_1_3_3_88_2
  doi: 10.1016/j.jelectrocard.2006.05.030
– ident: e_1_3_3_7_2
  doi: 10.1161/CIRCGENETICS.113.000292
– ident: e_1_3_3_19_2
  doi: 10.1136/openhrt-2013-000031
– ident: e_1_3_3_95_2
  doi: 10.1172/JCI33891
– ident: e_1_3_3_78_2
  doi: 10.1504/ijcbdd.2015.072082
– ident: e_1_3_3_70_2
  doi: 10.1161/01.res.87.10.910
– ident: e_1_3_3_27_2
  doi: 10.1161/01.CIR.0000145162.64183.C8
– ident: e_1_3_3_49_2
  doi: 10.1093/cvr/cvab045
– ident: e_1_3_3_81_2
  doi: 10.1093/bioinformatics/btr174
– ident: e_1_3_3_6_2
  doi: 10.3389/fphys.2013.00179
– ident: e_1_3_3_56_2
  doi: 10.1172/JCI39942
– ident: e_1_3_3_51_2
  doi: 10.1126/scitranslmed.aaf2584
– ident: e_1_3_3_55_2
  doi: 10.1038/s41586-019-1406-x
– ident: e_1_3_3_90_2
  doi: 10.1161/CIRCULATIONAHA.107.703330
– ident: e_1_3_3_2_2
  doi: 10.1016/j.jacc.2016.07.779
– ident: e_1_3_3_40_2
  doi: 10.1007/978-1-0716-0167-9_7
– ident: e_1_3_3_58_2
  doi: 10.1053/euhj.1997.0865
– ident: e_1_3_3_44_2
  doi: 10.1016/j.devcel.2016.01.009
– ident: e_1_3_3_73_2
  doi: 10.1111/bph.13563
– ident: e_1_3_3_48_2
  doi: 10.1161/CIRCEP.117.005282
– ident: e_1_3_3_24_2
  doi: 10.2337/db13-0420
– ident: e_1_3_3_87_2
  doi: 10.1016/j.ijcard.2014.04.133
– ident: e_1_3_3_15_2
  doi: 10.1016/j.cardiores.2004.09.021
– ident: e_1_3_3_104_2
  doi: 10.1371/journal.pone.0054131
– ident: e_1_3_3_28_2
  doi: 10.1038/srep04670
– ident: e_1_3_3_65_2
  doi: 10.1128/MCB.01923-08
– ident: e_1_3_3_69_2
  doi: 10.1161/01.CIR.0000139333.83620.5D
– ident: e_1_3_3_10_2
  doi: 10.1038/32675
SSID ssj0006375
Score 2.485531
Snippet Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene (sodium voltage-gated channel...
Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene SCN5A (sodium voltage-gated...
BACKGROUND: Brugada syndrome (BrS) is an inherited arrhythmia syndrome caused by loss-of-function variants in the cardiac sodium channel gene SCN5A (sodium...
SourceID hal
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 824
SubjectTerms Animals
Arrhythmias, Cardiac - genetics
Arrhythmias, Cardiac - metabolism
Brugada Syndrome
Humans
Life Sciences
Mice
Myocytes, Cardiac - metabolism
NAV1.5 Voltage-Gated Sodium Channel - genetics
NAV1.5 Voltage-Gated Sodium Channel - metabolism
Phenotype
Phosphatidylinositol 3-Kinases - metabolism
Receptors, Platelet-Derived Growth Factor - genetics
Receptors, Platelet-Derived Growth Factor - metabolism
Sodium - metabolism
Title Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003017-202303070-00006
https://www.ncbi.nlm.nih.gov/pubmed/36524479
https://www.proquest.com/docview/2755580672
https://hal.science/hal-04002896
Volume 147
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF6FIlUghKDlCJe2CPESOaTr-zENVC4kFaKJFJ6stb0mEW2MchSlf5c_wsweTkyCFHixItu72WS-nWvnIORNAlI65TZYqpkvLEcEtsWDMLGweVGWgEAQAeYO9869aOB8HLrDWu3XWtTSYp4005uteSX_Q1W4B3TFLNl_oGw5KdyAz0BfuAKF4bobjVHQmG2P_GsJAu-bbsjVkC2NQMWcNU6AHLh7C5hpnDba0-loOR9djXnjQhcskGcImCwC43pFNs6xQ7bK3UIEpVJRByNYZ22uq7Sd8TQ1X7mltc-aq-EE5izTga7HJSy_ap91nxcl_QvjTDfu_TJQ6JLf6A7cq1hM7bZgtozb8ldAM-dREWzo-QYWDbcOLd9WectNoRk0cyzHVQWQSg6uMkI1VN01fmzrJ0q02-oIaFNqeCg1OmdfOoOuqkEcoZOYNVseMHR7JSpNeEDUvog_vz-Nu2fnn6pPy5LdUbsbjwBRyCTBqPWuwUS_zcCWkRnpw1Uckmf7rmn3hz92nxzpNb3764oqStStEYbwbtpHd8m9nwWGXMy-y4yLNb2p_4Dc1wYPbSv0PiQ1MTkgh20ganG1pG-pDEGWZzsHZL-nIz0OyfIPbNMKtmmJbYrYpiW26Qrb1GCbArapwjYtsU2LnGps0yq2H5HB6Yd-J7J0mxArdRzfs1Kfu27i-SJ1Em6HqQc8JhM-CPEc7XNfhIFwWZAkDhP4Up4xUIvBbgk9loSsZT8me5NiIp4Syu005x7DEqGZk4gWTwXPszB08mM3E628TgLzv8eprqGPrVwuY2lLe8dxlWQxkCxWJKsTVg79oQrJ7DLoNWLIvL8dV3VyZGgfg2zAAz8-EcViFjMfq_lhsEWdPFGgKOeyPdhJjh_WiVVBSazyrzEoBb0lvoWbV2oGltRtn-2ypOfkzmrPvyB78-lCvATlfZ68kuD_DSWT7kk
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcriptional+Dysregulation+Underlies+Both+Monogenic+Arrhythmia+Syndrome+and+Common+Modifiers+of+Cardiac+Repolarization&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Bersell%2C+Kevin&rft.au=Yang%2C+Tao&rft.au=Mosley%2C+Jonathan&rft.au=Glazer%2C+Andrew&rft.date=2023-03-07&rft.pub=American+Heart+Association&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=115&rft.issue=5&rft.spage=315&rft.epage=330&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.122.062193&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_04002896v1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon